Transitioning to the "New Normal": What This Means for Oncology Care with Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care Artwork

Healthcare Goes Digital

We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post-COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result of this pandemic. At Impetus Digital, we believe all new, great ideas start with a conversation. Building on each other's ideas over time. One step at a time. This is how we believe positive disruption will occur. At Impetus Digital, we are leaders in delivering virtual collaboration experiences for life sciences companies. We offer the most comprehensive virtual meeting and event tools and services on the market. The Impetus InSite Platform® is a turn-key software solution that enables a “long-game” approach in connecting brands with key stakeholders, both synchronously and asynchronously. Its customizable, multilingual interface and its robust, pharma-compliant security make it the ideal choice for authentic engagement. Founded in 2008, we have over a decade of experience in virtualizing meetings and events. We offer a full range of strategic, medical writing, and digital services to help make the transition to hybrid events seamless. Visit our website www.impetusdigital.com to learn more!

All Episodes

Healthcare Goes Digital

Transitioning to the "New Normal": What This Means for Oncology Care with Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care

August 30, 2021 • Impetus Digital • Season 1 • Episode 142

Dr. Burt Zweigenhaft, Co-founder of the Association for Value-Based Cancer Care, shares his thoughts on the importance of patient-centricity in cancer care, current barriers to value-based care in the US and Canada, innovative cancer therapies, and how COVID-19 has affected oncology care delivery and research.

To find out more about Impetus: https://www.meetwithimpetus.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: https://www.impetusdigital.com/

Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/

Impetus Digital Twitter: https://twitter.com/impetus_digital

Impetus YouTube: https://www.youtube.com/ImpetusDigital

Dr. Burt Zweigenhaft: https://www.linkedin.com/in/burtzweigenhaft/

Association for Value-Based Cancer Care: https://www.valuebasedcancer.com/

Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.

Click the social media buttons to share this episode with your network!

To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: Home Page

LinkedIn: https://www.linkedin.com/company/impetus-digital/

Twitter: impetus_digital

YouTube: Impetus Digital